MedTrace Logo

Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular Degeneration

NCT02016508 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2013-12-24

No results posted yet for this study

Summary

The purpose of this Phase I/II study is to investigate the safety and preliminary efficacy of unilateral intravitreally transplantation of adult bone marrow stem cells in subjects with geographic atrophy secondary to age-related macular degeneration.

Conditions

  • Age Related Macular Degeneration

Interventions

DRUG

autologous bone marrow derived stem cells

intravitreal injection of autologous bone marrow stem cells in 0.1 ml volume

Sponsors & Collaborators

  • Hassan , Hosny , M.D. M.Sc

    collaborator UNKNOWN

  • Samour , Hany M.D. M.Sc

    collaborator UNKNOWN

  • Ismail , Mahmoud M.D. M.Sc

    collaborator UNKNOWN

  • Higazy , Hasan M.D. M.Sc

    collaborator UNKNOWN

  • Abou el kheir, Wael, M.D. M.Sc.

    collaborator UNKNOWN

  • Gabr, Hala , M.D. M.Sc.

    collaborator UNKNOWN

  • Bakry, Sayed , phD. M.Sc.

    collaborator UNKNOWN

  • Al-Azhar University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-04-30
Completion
2015-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02016508 on ClinicalTrials.gov